Compounded GLP-1 Medications Recalled Due to Sterility Concerns

Apothecary Pharma LLC is voluntarily recalling certain compounded tirzepatide injections, the active ingredient found in popular GLP-1 medications like Mounjaro and Zepbound, due to a 'lack of assurance of sterility.' The FDA has classified this as a Class II recall, indicating a low but possible risk of adverse health consequences. This recall specifically affects compounded versions, not the FDA-approved Mounjaro or Zepbound.